The Consumer Healthcare Products Association (CHPA) will hold its 2021 Regulatory, Scientific & Quality (RSQ) Conference virtually Sept. 9-10.

CHPA said its annual event brings together an array of highly respected experts to discuss timely regulatory, scientific, legal, and product quality topics affecting the consumer health care products industry. After a year of unprecedented change in health care, this year’s program will explore the evolving self-care landscape, including changes that are here to stay and those that lie ahead.

Using a dynamic virtual platform, attendees will hear distinguished speakers from the public and private sectors. The 2021 agenda will offer a range of key regulatory, scientific and product quality sessions over the course of two days.

This year’s virtual RSQ will feature a line-up of speakers from U.S. Food and Drug Administration (FDA)—including the Center for Drug Evaluation and Research (CDER), Center for Food Safety & Applied Nutrition (CFSAN), and Center for Devices and Radiological Health (CDRH), including:

• Janet Woodcock, MD, acting commissioner, FDA will provide remarks on FDA priorities with an emphasis on self-care.
• Cara Welch, PhD, acting director, Office of Dietary Supplement Programs, CFSAN, FDA and Jonette R. Foy, PhD, deputy office director, Office of Policy, CDRH, FDA, will update participants on CFSAN and CDRH staffing, key accomplishments and challenges, and top priorities in the coming year for dietary supplements and medical devices, respectively.

Attendees can participate in more than a dozen breakout sessions, featuring 30+ speakers on the latest in regulatory, scientific, and product quality topics in consumer healthcare as well as more than 15 on-demand sessions.

For more information, visit www.chpa.org.